CY1112061T1 - FIRE PRODUCTS AS CHINESE SUSPENSIONS - Google Patents

FIRE PRODUCTS AS CHINESE SUSPENSIONS

Info

Publication number
CY1112061T1
CY1112061T1 CY20111101113T CY111101113T CY1112061T1 CY 1112061 T1 CY1112061 T1 CY 1112061T1 CY 20111101113 T CY20111101113 T CY 20111101113T CY 111101113 T CY111101113 T CY 111101113T CY 1112061 T1 CY1112061 T1 CY 1112061T1
Authority
CY
Cyprus
Prior art keywords
suspensions
chinese
compounds
fire products
disease
Prior art date
Application number
CY20111101113T
Other languages
Greek (el)
Inventor
Qiang Ding
Nathanael Schiander Gray
Bing Li
Yi Liu
Taebo Sim
Tetsuo Uno
Guobao Zhang
Soldermann Carole Pissot
Werner Breitenstein
Guido Bold
Giorgio Caravatti
Pascal Furet
Vito Guagnano
Marc Lang
Paul W Manley
Joseph Schoepfer
Carsten Spanka
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0512324.5A external-priority patent/GB0512324D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1112061T1 publication Critical patent/CY1112061T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά σε ενώσεις του τύπου (Ι), όπου οι υποκαταστάτες Χ1, R1, R2, R3 και R4 έχουν τη σημασία που δίνεται και εξηγείται στην περιγραφή της εφεύρεσης, σε μεθόδους για την παρασκευή αυτών των ενώσεων, σε φαρμακευτικές συνθέσεις που τις περιέχουν, στη χρήση αυτών προαιρετικά σε συνδυασμό με μία ή περισσότερες άλλες φαρμακευτικά δραστικές ενώσεις για τη θεραπευτική αντιμετώπιση μιας νόσους η οποία αποκρίνεται στην αναστολή της ενεργότητας της πρωτεϊνικής κινάσης, και σε μια μέθοδο για τη θεραπευτική αντιμετώπιση μιας τέτοιας νόσου.The invention relates to compounds of formula (I), wherein the substituents X1, R1, R2, R3 and R4 have the meaning given and explained in the description of the invention, in processes for the preparation of these compounds, in pharmaceutical compositions containing them. in the use thereof optionally in combination with one or more other pharmaceutically active compounds for the treatment of a disease in response to inhibition of protein kinase activity, and a method for the treatment of such a disease.

CY20111101113T 2004-06-24 2011-11-17 FIRE PRODUCTS AS CHINESE SUSPENSIONS CY1112061T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58242504P 2004-06-24 2004-06-24
GBGB0512324.5A GB0512324D0 (en) 2005-06-16 2005-06-16 Organic compounds
EP05756693A EP1761505B1 (en) 2004-06-24 2005-06-23 Pyrimidine urea derivatives as kinase inhibitors

Publications (1)

Publication Number Publication Date
CY1112061T1 true CY1112061T1 (en) 2015-11-04

Family

ID=49584524

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101113T CY1112061T1 (en) 2004-06-24 2011-11-17 FIRE PRODUCTS AS CHINESE SUSPENSIONS

Country Status (2)

Country Link
CY (1) CY1112061T1 (en)
PE (1) PE20131129A1 (en)

Also Published As

Publication number Publication date
PE20131129A1 (en) 2013-10-16

Similar Documents

Publication Publication Date Title
CY1108813T1 (en) Tyrosine kinase inhibitors
TW200615266A (en) Organic compounds
CY1110177T1 (en) Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS
CY1117217T1 (en) COMPOSITION AND ANTI-VISUAL ACTIVITY OF SUBSTITUTED AZAIDOLOOXOXIC PRODUCERS OF Piperazine
CY1105362T1 (en) SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DRUGS
CY1115719T1 (en) NEW PHARMACEUTICAL COMBINATIONS FOR THE RESPIRATORY DISEASE TREATMENT
CY1114539T1 (en) The usefulness of imidazopyridazinecarbonitriles as suspended kinases
CY1112376T1 (en) 2,3,4,9-tetrahydro-1H-carvasol derivative as CRTH2 receptor antagonists
UY29633A1 (en) OXINDOL DERIVATIVES
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
CY1106679T1 (en) AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS
NO20070529L (en) Quinazoline dione derivatives as parp inhibitors
NO20051966L (en) New pyrimidinamide derivatives and their use
ATE499372T1 (en) AZABENZIMIDALZOL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTICANCER AGENTS
CY1111203T1 (en) 4-ANILINOKINOLINO-3-CARBOXAMIDE AS MOVEMENT INHIBITORS CSF-1R
CY1111022T1 (en) NEW PHARMACEUTICAL COMBINATIONS FOR THE RESPIRATORY DISEASE TREATMENT
CY1113911T1 (en) SF5 DERIVATIVES AS PAR1 INHIBITORS, THEIR PREPARATION AND THEIR USE AS MEDICINES
CY1113482T1 (en) SUSPENDED SIGNIFICANT SIGNS
CY1109964T1 (en) Heterocyclic Rings Synthesized with 1,4-Dihydropyridine, Their Preparation Process, Usage, and Their Compositions
BRPI0519267A2 (en) quinoline derivative, its use, production and medicine containing the same
CY1112451T1 (en) METHOD FOR REDUCING GASTROENTRIC TOXICITY BY TEGAPURIS ADMINISTRATION
CY1112173T1 (en) THE USE OF CILOBRADINE OR THESE PHARMACEUTICAL SALVES FOR THE TREATMENT OR PREVENTION OF HEART DEFICIENCY
ATE439361T1 (en) 7H-PYRIDOÄ3,4-DÜPYRIMIDINE-8-ONE, THEIR PREPARATION AND THEIR USE AS PROTEIN KINASE INHIBITORS
FR2894578B1 (en) HETEROCYCLIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
EA200600833A1 (en) TIAZOLIDINONONY, THEIR RECEIVING AND APPLICATION AS PHARMACEUTICAL AGENTS